St. Jude scientist wins International Society of Experimental Hematology award
Brian P. Sorrentino, M.D., of St. Jude Children's Research Hospital, has won a prestigious award from the International Society of Experimental Hematology. ... Sorrentino, director of the St. Jude Experimental Hematology division, won the 2005 ISEH McCulloch and Till Lecturship and Award, which was established to recognize the contributions of younger investigators in the field. ... The award wil...St. Jude scientist to lead NCI Pediatric Preclinical Testing Program
The National Cancer Institute has announced the establishment of the Pediatric Preclinical Testing Program (PPTP), a program that will systematically test 10-15 agents or combinations of agents annually in preclinical models of common childhood cancers. ...The PPTP is supported through an NCI research contract to St. Jude Children's Research Hospital with St. Jude Molecular Pharmacology Chair, Pe...St. Jude helps South American community achieve improved survival rates for leukemia
(MEMPHIS, TENN.--May 25, 2004) The city of Recife, Brazil, experienced a significant improvement in outcome among children treated for acute lymphoblastic leukemia (ALL) during the past decade, even though the community is resource-poor and most patient families are impoverished. These findings are published in the May 26 issue of the Journal of the American Medical Association by physicians at S...St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
St. Paul, MN, March 9, 2004 -- St. Jude Medical, Inc. (NYSE: STJ) announced today that data from its RHYTHM (Resynchronization HemodYnamic Treatment for Heart Failure Management) ICD clinical trial showed a statistically significant improvement in peak VO2 and exercise duration for patients treated with cardiac resynchronization therapy (CRT). All prospectively defined primary safety and efficac...St. Jude Medical announces PAVE and DINAMIT clinical trial results
ST. PAUL, MN, March 8, 2004 -- St. Jude Medical, Inc. (NYSE:STJ) announced today the results of the PAVE (Post AV Nodal Ablation Evaluation) and DINAMIT (Defibrillator IN Acute Myocardial Infarction Trial) clinical studies at the American College of Cardiology's (ACC) Annual Scientific Session 2004 in New Orleans, Louisiana. Both studies were sponsored by St. Jude Medical.... ...The data f...U.S. is poorly prepared for influenza pandemic, St. Jude experts warn
MEMPHIS, TENN. -- The United States is not adequately prepared to respond to a worldwide outbreak of influenza, which many experts say could be imminent. This finding, reported in the Nov. 28 issue of the journal Science, is authored by researchers at St. Jude Children's Research Hospital. ...The St. Jude investigators warn that although there is excellent influenza vaccine technology available t...St. Jude leukemia therapy overcomes differences in treatment outcome between black, white children
(MEMPHIS, TENN.--October 14, 2003) Investigators at St. Jude Children's Research Hospital have found that black children are equally likely as white children to benefit from improved treatment for acute lymphoblastic leukemia (ALL), if given equal access to the most advanced therapies.... ... This finding--that black and white children had virtually equal rates of survival over 10 years--contrast...St. Jude identifies ways to improve treatment of childhood leukemia in Honduras
(MEMPHIS, TENN. August 28, 2003) Investigators at St. Jude Children's Research Hospital and Hospital Escuela (Tegucigalpa, Honduras) have identified ways to improve treatments and cure rates for Honduran children with acute lymphoblastic leukemia (ALL). Their findings are published in the August 30 issue of The Lancet. ...Many children in Honduras receiving the most advanced treatment for ALL, th...St. Jude Medical announces publication of results of its ADOPT-A trial
St. Paul, MN, August 19, 2003 -- St. Jude Medical, Inc. (NYSE:STJ) today announced publication of the results of its Atrial Dynamic Overdrive Pacing Trial-A in the August 20th edition of the Journal of the American College of Cardiology. The ADOPT-A clinical trial evaluated the use of the Company's AF Suppression(tm) pacing algorithm for the suppression of symptomatic paroxysmal and persistent a...St. Jude Children's Research Hospital to manufacture investigative drugs and vaccines
(Memphis, TN --- April 21, 2002) St. Jude Children's Research Hospital has become the only pediatric cancer research center in the United States to open a Good Manufacturing Practices (GMP) facility for producing vaccines, drugs, proteins, gene-based molecules and other biological products. The facility also has Biological Safety Level (BSL) 3 laboratories to accommodate work with microorganisms...St. Jude to receive multi-million dollar grant for sickle cell program
(MEMPHIS, TENN. Oct. 18, 2002) St. Jude Children's Research Hospital has competed for and will receive a multi-million dollar, five-year grant to expand its sickle cell disease program. St. Jude is one of 10 federally funded comprehensive sickle cell centers to receive a grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). ... When funded nex...